CompanyPrivateSan Diego, CA

Avenzo Therapeutics, Inc

SEC EDGAR ClinicalTrials.gov

8-KNov 10Latest SEC filing

Form DSep 5$47M sold

November 2026

Rallybio sets 1-for-2 reverse stock split ahead of Avenzo merger

Nov 10M&ARallybio Corp

Rallybio and Avenzo postpone merger closing past November 6, 2026 target

Nov 6M&ARallybio Corp

Rallybio stockholders approve Avenzo merger, name change, and reverse split

Nov 4PeopleRallybio Corp